Business Description
Artivion Inc
NAICS : 339113
SIC : 3841
ISIN : US2289031005
Share Class Description:
AORT: Ordinary SharesTotal Employee Number:
1,800Description
Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.22 | |||||
Equity-to-Asset | 0.51 | |||||
Debt-to-Equity | 0.57 | |||||
Debt-to-EBITDA | 3.97 | |||||
Interest Coverage | 1.25 | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | 2.54 | |||||
Beneish M-Score | -2.61 | |||||
WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 6.1 | |||||
3-Year EBITDA Growth Rate | 28.2 | |||||
3-Year EPS without NRI Growth Rate | 132.7 | |||||
3-Year Book Growth Rate | 10 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 71.13 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 10.87 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 80.72 | |||||
9-Day RSI | 66.89 | |||||
14-Day RSI | 54.89 | |||||
3-1 Month Momentum % | -36.27 | |||||
6-1 Month Momentum % | -49.92 | |||||
12-1 Month Momentum % | -24.27 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 3.86 | |||||
Quick Ratio | 2.8 | |||||
Cash Ratio | 0.6 | |||||
Days Inventory | 201.87 | |||||
Days Sales Outstanding | 71.46 | |||||
Days Payable | 36.81 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -5.8 | |||||
Shareholder Yield % | 8.91 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 64.55 | |||||
Operating Margin % | 6.63 | |||||
Net Margin % | 2.55 | |||||
EBITDA Margin % | 14.18 | |||||
FCF Margin % | 3.18 | |||||
OCF Margin % | 12.64 | |||||
ROE % | 2.85 | |||||
ROA % | 1.37 | |||||
ROIC % | 2.71 | |||||
3-Year ROIIC % | 14.84 | |||||
ROC (Joel Greenblatt) % | 15.03 | |||||
ROCE % | 5.41 | |||||
Years of Profitability over Past 10-Year | 4 | |||||
Moat Score | 4 | |||||
Tariff Resilience Score | 6 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 98.38 | |||||
Forward PE Ratio | 190.4 | |||||
PE Ratio without NRI | 36.32 | |||||
Price-to-Owner-Earnings | 259.45 | |||||
PEG Ratio | 1.78 | |||||
PS Ratio | 2.5 | |||||
PB Ratio | 2.54 | |||||
Price-to-Tangible-Book | 25.95 | |||||
Price-to-Free-Cash-Flow | 72.65 | |||||
Price-to-Operating-Cash-Flow | 19.74 | |||||
EV-to-EBIT | 32.34 | |||||
EV-to-EBITDA | 20.73 | |||||
EV-to-Revenue | 2.94 | |||||
EV-to-Forward-Revenue | 2.78 | |||||
EV-to-FCF | 92.48 | |||||
Price-to-GF-Value | 0.83 | |||||
Price-to-Projected-FCF | 3.47 | |||||
Price-to-DCF (Earnings Based) | 3.15 | |||||
Price-to-DCF (FCF Based) | 6.3 | |||||
Price-to-Median-PS-Value | 0.78 | |||||
Price-to-Peter-Lynch-Fair-Value | 2.01 | |||||
Price-to-Graham-Number | 6.49 | |||||
Earnings Yield (Greenblatt) % | 3.09 | |||||
FCF Yield % | 1.27 | |||||
Forward Rate of Return (Yacktman) % | 17.66 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NYSE:AORT
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Artivion Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 458.689 | ||
| EPS (TTM) ($) | 0.24 | ||
| Beta | 1.7455 | ||
| 3-Year Sharpe Ratio | 0.42 | ||
| 3-Year Sortino Ratio | 0.73 | ||
| Volatility % | 61.71 | ||
| 14-Day RSI | 54.89 | ||
| 14-Day ATR ($) | 1.235479 | ||
| 20-Day SMA ($) | 21.083 | ||
| 12-1 Month Momentum % | -24.27 | ||
| 52-Week Range ($) | 19.16 - 48.25 | ||
| Shares Outstanding (Mil) | 48.54 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Artivion Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Artivion Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Third quarter earnings conference call for 2026 | 2026-11-06 16:30 | In 132 days | ||
| Third quarter earnings results for 2026 | 2026-11-06 | In 131 days | ||
| Second quarter earnings conference call for 2026 | 2026-08-07 16:30 | In 41 days | ||
| Second quarter earnings results for 2026 | 2026-08-07 | In 40 days | ||
| Guidance call for 2026 | 2026-06-16 13:00 | 21.07 (+3.49%) | ||
| General meeting for 2026 | 2026-05-12 09:00 | 23.81 (-7.78%) | ||
| First quarter earnings conference call for 2026 | 2026-05-07 16:30 | 34.73 (-3.23%) | ||
| First quarter earnings results for 2026 | 2026-05-07 | 34.73 (-3.23%) | ||
| Oppenheimer 36th Annual Healthcare MedTech & Services Conference | 2026-03-17 09:20 | 37.40 (+0.70%) | ||
| Annual report for 2025 | 2026-02-18 | 36.50 (-1.96%) |
Show
Entries
Artivion Inc Frequently Asked Questions
What is Artivion Inc(AORT)'s stock price today?
The current price of AORT is $23.61. The 52 week high of AORT is $48.25 and 52 week low is $19.16.
When is next earnings date of Artivion Inc(AORT)?
The next earnings date of Artivion Inc(AORT) is 2026-08-07 Est..
Does Artivion Inc(AORT) pay dividends? If so, how much?
Artivion Inc(AORT) does not pay dividend.
Guru Commentaries on NYSE:AORT
Press Release
Articles on Artivion Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers